Nevertheless, aberrant expression and mutations in NASH-HCCs affected different genes that were commonly enriched in five core pathways of calcium signaling, insulin signaling, cell adhesion, axon guidance and metabolism. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.